SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001562180-20-001187
Filing Date
2020-02-13
Accepted
2020-02-13 18:22:58
Documents
1
Period of Report
2020-02-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4/A  
1 PRIMARY DOCUMENT primarydocument.xml 4/A 17277
  Complete submission text file 0001562180-20-001187.txt   18671
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Issuer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANTIGENICS INC. 3 FORBES RD LEXINGTON MA 02421
Business Address
Valentine Karen (Reporting) CIK: 0001437152 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38584 | Film No.: 20612678